CTOs on the Move

Acucela

www.acucela.com

 
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.acucela.com
  • 1301 2nd Ave # 1900
    Seattle, WA USA 98101
  • Phone: 206.805.8300

Executives

Name Title Contact Details

Similar Companies

Conroe Regional Medical Center

Conroe Regional Medical Center is a Conroe, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

County Of Ripley

County Of Ripley is a Doniphan, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Denver-Vail Orthopedics

Denver-Vail Orthopedics is a Denver, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nymox

NYMOZARFEX (TM) is given in an in-office procedure that is administered in a few minutes without need of anesthesia or analgesia. The drug has been tested in clinical trials involving overall more than 1750 patients with over 1600 injections administered including over 1200 Fexapotide administrations. Fexapotide has led to significant long-term improvements and has shown an excellent safety profile without the side effects normally associated with existing BPH treatments.

Cirrus Health

Cirrus Health is an organization uniquely qualified to successfully adapt to the ever-changing healthcare environment. While the complexity of today's healthcare creates barriers for some companies, it is a market of opportunities for Cirrus Health.